CAM
BNGO icon

Carret Asset Management’s Bionano Genomics BNGO Stock Holding History

Carret Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
125,000
+55,000
+79% +$66.3K 0.01% 303
2026
Q1 		$81.9K Buy
70,000
+25,900
+59% +$33.2K 0.01% 287
2025
Q4 		$67.5K Buy
44,100
+19,100
+76% +$33.1K 0.01% 291
2025
Q3 		$42.8K Buy
+25,000
New +$79.5K ﹤0.01% 285
2025
Q1 		– Sell
-1,983
Closed -$34.3K – 275
2024
Q4 		$34.3K Buy
1,983
+565
+40% +$9.66K ﹤0.01% 280
2024
Q3 		$38.6K Buy
1,418
+668
+89% +$20.8K ﹤0.01% 282
2024
Q2 		$30.5K Buy
750
+275
+58% +$15.1K ﹤0.01% 270
2024
Q1 		$31.6K Buy
475
+175
+58% +$13.1K ﹤0.01% 273
2023
Q4 		$34K Buy
+300
New +$31.3K ﹤0.01% 270
2023
Q3 		– Sell
-50
Closed -$18.3K – 275
2023
Q2 		$18.3K Buy
50
+27
+117% +$12.2K ﹤0.01% 266
2023
Q1 		$16K Buy
23
+3
+15% +$2.67K ﹤0.01% 265
2022
Q4 		$18K Buy
20
+3
+18% +$3.77K ﹤0.01% 272
2022
Q3 		$18K Hold
17
– – ﹤0.01% 268
2022
Q2 		$14K Hold
17
– – ﹤0.01% 275
2022
Q1 		$26K Hold
17
– – ﹤0.01% 294
2021
Q4 		$30K Sell
17
-6
-26% -$16K ﹤0.01% 295
2021
Q3 		$77K Hold
23
– – 0.01% 292
2021
Q2 		$103K Hold
23
– – 0.01% 291
2021
Q1 		$113K Sell
23
-17
-43% -$95.8K 0.01% 277
2020
Q4 		$74K Buy
+40
New +$14.9K 0.01% 269

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Carret Asset Management's BNGO Position: Q2 2026 in Review

Carret Asset Management increased its Bionano Genomics (BNGO) stake by 79% in Q2 2026, buying an estimated $66.3K and bringing the position to 125,000 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #303.

Carret Asset Management first reported a position in BNGO in Q4 2020 and has held it in 20 quarters since. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Carret Asset Management held 125,000 shares of Bionano Genomics worth $141K as of Q2 2026.
  • Carret Asset Management bought 55,000 Bionano Genomics shares in Q2 2026, an estimated $66.3K.
  • Bionano Genomics made up 0.01% of Carret Asset Management's portfolio in Q2 2026, its #303 holding.
  • Carret Asset Management first reported a position in Bionano Genomics in Q4 2020 and has held it in 20 quarters since.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Carret Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.